Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07000851 · ClinicalTrials.gov registry record
Imaging Studies in Corticobasal Syndrome
A clinical trial of Corticobasal Degeneration and Corticobasal Syndrome, sponsored by Jennifer Whitwell.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT07000851 is a study of Corticobasal Degeneration and Corticobasal Syndrome that is actively recruiting participants, run by Jennifer Whitwell. The registered enrollment target is 80 participants, below the 1,977-participant average among 7 other Corticobasal Degeneration trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07000851, a study of Corticobasal Degeneration and Corticobasal Syndrome, is actively recruiting participants, sponsored by Jennifer Whitwell.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST C-11 ER176 Radiotracer
- DIAGNOSTIC_TEST C-11 PiB
- DIAGNOSTIC_TEST AV1451 Tau
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2031-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07000851
The ClinicalTrials.gov registry entry for NCT07000851 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,977-participant average among 7 other Corticobasal Degeneration trials with a reported enrollment target (96% lower). The listed sponsor is Jennifer Whitwell, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Corticobasal Degeneration appearing as the primary indexed condition, and to 3 interventions - of which C-11 ER176 Radiotracer is the first listed.
NCT07000851 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07000851 about?
NCT07000851 is a clinical study titled "Imaging Studies in Corticobasal Syndrome". The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
What is the current status of trial NCT07000851?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-06-25. Estimated completion is 2031-03-30.
What conditions does trial NCT07000851 study?
This clinical trial studies the following conditions: Corticobasal Degeneration, Corticobasal Syndrome, Corticobasal Degeneration (CBD), Corticobasal Syndrome(CBS), Corticobasal Syndrome (CBS).
What interventions are being tested in trial NCT07000851?
The interventions under investigation include: C-11 ER176 Radiotracer (DIAGNOSTIC_TEST), C-11 PiB (DIAGNOSTIC_TEST), AV1451 Tau (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07000851?
This trial is sponsored by Jennifer Whitwell, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07000851 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corticobasal Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gait Analysis in Neurological Disease
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
RECRUITING · NA
-
The CurePSP Genetics Program
RECRUITING
-
Modifiable Variables in Parkinsonism (MVP)
RECRUITING
-
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.